Navigation Links
Sinobiopharma Secures Rights to Seven Key Patents
Date:4/27/2009

NANJING, China, April 27 /PRNewswire-FirstCall/ -- Sinobiopharma Inc. ("Sinobiopharma ", or "the Company") (OTC Bulletin Board: SNBP) is pleased to announce that it has secured rights to seven key patents from Company CEO Dr. Lequn Huang and the patents' co-holders. The patents that will significantly enhance Sinobiopharma's ability to execute on its mission of bringing safe, low-cost, high-efficacy biopharmaceuticals to market.

The patents are for the following:

  1. Synthesis of amantadine hydrochloride
  2. Method for preparation of 17-acylsinomenine derivatives
  3. Preparation of 17-sulfonylsinomenine
  4. Preparation of N-substituted sinomenine
  5. Method for preparation of Sinomenine compound having dextro-rotary C ring-deficient morphinan skeleton
  6. Synthesis of Eplerenone from 11 -hydroxycanrenone
  7. Method for resolving tetrahydroisoquinoline racemate

Sinobiopharma will be applying these patents as well as using its own innovative applications of them in new drug development.

About Sinobiopharma

Sinobiopharma Inc. is a fully integrated and highly innovative biotechnology company engaged in the research and development, manufacture and marketing of biopharmaceutical products in China, the world's fastest growing pharmaceutical market. Known as Dong Ying (Jiangsu) Pharmaceutical Co. Ltd. in China, the Company's current therapeutic focus is on anesthesia-assisted agents and cardiovascular drugs.

FORWARD LOOKING STATEMENTS

This news release may include "forward-looking statements" regarding Sinobiopharma, Inc., and its subsidiaries, business and project plans. Such forward looking statements are within the meaning of Section 27A of the Securities Act of 1933, as amended, and section 21E of the United States Secu
'/>"/>

SOURCE Sinobiopharma, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Sinobiopharma Reports a 141% Increase in Revenues From Unaudited Financial Results for the 9 Month Period Ended February 28, 2009
2. Sinobiopharma Reports a 41% Increase in Revenues From Unaudited Financial Results for the 9 Month Period Ended February 28, 2009
3. Sinobiopharma, Inc. Appoints New Director of Marketing
4. Sinobiopharma Signs Export Agreement With U.S. Pharmaceutical Supplier
5. Sinobiopharma Reports Financial Highlights for Six-Month Period Ending November 30, 2008
6. Aerovance Secures $38 Million in Equity Financing
7. VIA Pharmaceuticals Secures Financing Up to $10.0 Million
8. Pearl Therapeutics Secures $8 Million in Debt Financing
9. Heptares Secures GBP21 Million in Series A Fund Raising to Accelerate Development of Pipeline of Small Molecules Against High-Value GPCR Drug Targets
10. Sopherion Therapeutics Secures $55 Million in Series C Funding
11. Northwest Biotherapeutics Secures $700,000 Equity Financing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... , July 10, 2014  Kainos Capital, a firm ... today announced that it has acquired the Slim-Fast brand ... the business. Terms of the transaction were not disclosed. ... meal replacement business that markets ready-to-drink shakes, powders, bars ... America and in the United ...
(Date:7/10/2014)... DUBLIN , July 10, 2014 ... the addition of the "International Photonic Integrated ... - Forecasts to 2019" report to their ... The concept of photonic integration traces ... twentieth century. The promise of photonic integration went ...
(Date:7/10/2014)... April 15, 2014 -- According to the International ... nuclear security comes from terrorists acquiring sufficient quantities ... construct a crude nuclear explosive device. The IAEA ... trafficking have involved gram-level quantities, which can be ... According to a new study appearing this week ...
(Date:7/10/2014)... D.C., June 17, 2014 Using microscopic polymer ... specific gases, researchers at MIT,s Quantum Photonics Laboratory ... levels in the parts-per-billion range. Optical sensors are ... their high signal-to-noise ratio, compact, lightweight nature, and ... gas sensors had been developed before, the MIT ...
Breaking Biology Technology:Kainos Capital Acquires Slim-Fast From Unilever 2International Photonic Integrated Circuit (Monolithic Integration, Hybrid Integration, Module Integration) Market - Forecasts to 2019 2Sensitive detection method may help impede illicit nuclear trafficking 2Swell new sensors 2
... 11 Idenix Pharmaceuticals, Inc., (Nasdaq: IDIX ... results for the fourth quarter of 2008 on Tuesday, ... conjunction with the issuance of the press release, Idenix ... ET on Tuesday, February 17, 2009 to discuss the ...
... XTL,Biopharmaceuticals Ltd. (Nasdaq: XTLB ; TASE: ... Shweiger have been appointed to XTL,s Board of,Directors, effective ... assuming,the role of Co-Chief Executive Officer, with no remuneration, ... Ron Bentsur, Co-Chief Executive Officer ...
... Victhom Human Bionics Inc., "Victhom" (TSX: VHB), announced today ... and treatment of a physiological disorder that most likely ... seizure. , Victhom has recently filed a patent application ... sudden unexpected death in epilepsy (SUDEP) using its neuromodulation ...
Cached Biology Technology:XTL Biopharmaceuticals Announces Appointment of David Grossman and Boaz Shweiger to Board of Directors 2XTL Biopharmaceuticals Announces Appointment of David Grossman and Boaz Shweiger to Board of Directors 3Victhom announces the filing of a patent application to address sudden unexplained death in epilepsy (SUDEP) 2Victhom announces the filing of a patent application to address sudden unexplained death in epilepsy (SUDEP) 3
(Date:7/10/2014)... Interdisciplinary Research (MIIR) and the Marshall University Joan ... will be partnering with an international biosciences company ... agreement with Shanghai-based HD Biosciences Co. Ltd., the ... of discovery and development of these new drugs. ... and commercialization rights to products developed through the ...
(Date:7/10/2014)... around a family of enzymes known as heme enzymes, ... their active site. At the centre of the heme ... (ferryl) when a reacting heme is in an intermediate ... unanswered for decades is whether this oxidation involves just ... Resolving this fundamental question has implications for understanding oxidative ...
(Date:7/10/2014)... Geostationary Operational Environmental Satellite or GOES-West satellite spotted ... fires raging in Canada,s Northwestern Territories. , At ... 2014, GOES-West captured this image of the brownish-colored ... Territories that drifted all the way into South ... GOES Project at NASA Goddard Space Flight Center, ...
Breaking Biology News(10 mins):Marshall University to partner with international company in drug development venture 2Neutron crystallography solves long-standing biological mystery 2Neutron crystallography solves long-standing biological mystery 3
... a looming water crisis, driven by climate change, growing ... of this issue, the National Science Foundation has selected ... Engineering Research Center (ERC) to address this challenge by ... initial grant is $18.5 million spread over five years, ...
... Scientists at the U.S. Department of Energy,s (DOE) Brookhaven ... the metabolic processes in rapeseed plants - particularly those ... Their goal is to find ways to optimize the ... renewable resources for fuel and industrial chemicals. The ...
... ,(Phoenix ... awarded Robert Garfield, PhD, a researcher at St. Joseph,s Hospital and Medical ... to prevent post-partum hemorrhage. The grant was one of 88 awarded ... help lower the barriers for testing innovative ideas in global health. Phase ...
Cached Biology News:Re-inventing America's urban water infrastructure 2Re-inventing America's urban water infrastructure 3Re-inventing America's urban water infrastructure 4Modeling plant metabolism to optimize oil production 2Modeling plant metabolism to optimize oil production 3
RAT ANTI MOUSE F4/80 ANTIGEN:BIOTIN Immunogen: Thioglycollate stimulated peritoneal macrophages from C57/BL mice...
Sterile glass 5 mm beads that make spreading bacterial and yeast cultures easy. Can be washed, autoclaved and reused....
REGULATED IN DEVELOPMENT AND DNA DAMAGE RESPONSES 1,HIF-1 responsive RTP801...
4-Hydroxy-3-iodo-5-nitrophenylacetyl hapten is conjugated to BSA protein through lysine by amide bonds....
Biology Products: